- Pharmaceutical packaging plays a significant role in the pharmaceutical industry for the safety of the drugs and medicine against all unfavourable external influences. These influences can change the properties of the drug or medicine and cause mechanical damage, physical damage, biological contamination and degradation and also counterfeiting
- The North America pharmaceutical packaging market is expected to rise in demand due to the high demand for drug delivery devices and blister packaging
- U.S. dominates the Europe pharmaceutical packaging market, accounting for the largest regional share of approximately 62.37% in 2024. This leadership is attributed to its strong pharmaceutical manufacturing base, high healthcare expenditure, and advanced packaging technology adoption. The presence of leading pharma companies and a robust regulatory environment further reinforces U.S. position as a key driver in the region's packaging evolution
- In 2025, the Plastics segment is expected to dominate the material type segment of the North America Pharmaceutical Packaging market, holding a market share of approximately 57.35%. This dominance is driven by plastics' versatility, lightweight nature, and cost-effectiveness, along with their suitability for a wide range of pharmaceutical products such as blister packs, bottles, syringes, and pouches
